NYSE:BDX

Becton Dickinson is a global medical technology company engaged in the development, manufacture, and sale of a broad range of medical supplies, devices, and diagnostic products. The company serves customers including healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry, and individual consumers in more than 190 countries worldwide.

Becton Dickinson’s products are manufactured and sold in the USA, Europe, EMA, Greater Asia, Latin America, and Canada. The company operates through a strong network of independent distribution channels and sales representatives. It also has extensive R&D facilities in North America, China, France, India, Ireland, and Singapore.

Becton Dickinson’s business segments are BD Medical which is the largest, accounting for 54% of (2018) revenues, BD Life Sciences (27%) and BD Interventional (19%). By solutions, medication delivery is the largest constituting 23% of (2018) revenues, followed by medication management (16%), pharmaceutical, preanalytical, diagnostic systems, and diabetes care, biosciences, urology, etc.